Table 3.
Change of TG, Chol., LDL, HDL, VEP15, RPM-score, and LOS T-score during the intervention period, stratified into three groups according to the daily dosage of DHA (0, >0 to <1.9, ≥1.9 mg/kg&day); changes in the three groups were compared by ANOVA.
| 0 (n ≥ 15) | >0 to <1.9 (n ≥ 15) | ≥1.9 (n ≥ 42) | p-Value (ANOVA) | |
|---|---|---|---|---|
| DHA (mg/L) | 0.0 ± 9.1 | 5.1 ± 10.3 | 19.5 ± 13.6 | 1.3 × 10−8 |
| TG (mmol/L) | −0.1 ± 0.7 | 0.0 ± 0.5 | 0.1 ± 0.5 | 0.595 |
| Chol. (mmol/L) | −0.1 ± 0.6 | 0.0 ± 0.5 | 0.1 ± 0.5 | 0.795 |
| LDL (mmol/L) | −0.3 ± 1.2 | 0.2 ± 0.5 | −0.1 ± 0.5 | 0.397 |
| HDL (mmol/L) | 0.0 ± 0.3 | 0.0 ± 0.3 | 0.0 ± 0.2 | 0.865 |
| VEP15 (ms) | 1.3 ± 3.5 | 0.5 ± 8.7 | −0.6 ± 4.7 | 0.527 |
| RPM-score | 9.5 ± 13.5 | 2.2 ± 15.8 | 1.6 ± 13.8 | 0.016 |
| LOS T-score | 2.9 ± 7.0 | 4.2 ± 6.3 | 0.8 ± 9.1 | 0.371 |